Free Trial

Empower Advisory Group LLC Makes New Investment in American Healthcare REIT, Inc. (NYSE:AHR)

American Healthcare REIT logo with Finance background

Empower Advisory Group LLC acquired a new position in shares of American Healthcare REIT, Inc. (NYSE:AHR - Free Report) in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 26,030 shares of the company's stock, valued at approximately $679,000.

Other institutional investors have also made changes to their positions in the company. Mirae Asset Global Investments Co. Ltd. lifted its holdings in American Healthcare REIT by 34.7% in the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 2,537 shares of the company's stock valued at $66,000 after acquiring an additional 654 shares during the last quarter. Kozak & Associates Inc. acquired a new stake in American Healthcare REIT in the 3rd quarter valued at about $28,000. Kessler Investment Group LLC acquired a new stake in American Healthcare REIT in the 3rd quarter valued at about $48,000. Kiely Wealth Advisory Group Inc. acquired a new stake in American Healthcare REIT in the 2nd quarter valued at about $30,000. Finally, Creekmur Asset Management LLC purchased a new stake in American Healthcare REIT during the third quarter valued at about $54,000. 16.68% of the stock is owned by institutional investors and hedge funds.

American Healthcare REIT Price Performance

Shares of NYSE:AHR traded up $0.81 on Friday, hitting $27.03. The stock had a trading volume of 1,049,425 shares, compared to its average volume of 1,454,093. American Healthcare REIT, Inc. has a twelve month low of $12.63 and a twelve month high of $27.77. The company has a debt-to-equity ratio of 0.60, a quick ratio of 0.29 and a current ratio of 0.29. The firm's 50 day moving average price is $25.16 and its 200-day moving average price is $19.21. The company has a market capitalization of $3.56 billion and a price-to-earnings ratio of -55.23.

American Healthcare REIT (NYSE:AHR - Get Free Report) last issued its quarterly earnings results on Tuesday, November 12th. The company reported ($0.03) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.32 by ($0.35). The company had revenue of $523.81 million for the quarter, compared to analyst estimates of $474.26 million. American Healthcare REIT had a negative return on equity of 1.96% and a negative net margin of 1.84%. The company's revenue for the quarter was up 12.8% on a year-over-year basis. On average, equities research analysts predict that American Healthcare REIT, Inc. will post 1.41 earnings per share for the current year.

American Healthcare REIT Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, October 18th. Shareholders of record on Friday, September 20th were issued a dividend of $0.25 per share. The ex-dividend date of this dividend was Friday, September 20th. This represents a $1.00 annualized dividend and a yield of 3.70%. American Healthcare REIT's dividend payout ratio is currently -208.33%.

Wall Street Analysts Forecast Growth

AHR has been the subject of a number of analyst reports. Colliers Securities raised shares of American Healthcare REIT from a "hold" rating to a "moderate buy" rating in a research note on Sunday, October 13th. Truist Financial increased their price objective on American Healthcare REIT from $27.00 to $29.00 and gave the stock a "buy" rating in a report on Friday. JMP Securities increased their price target on American Healthcare REIT from $18.00 to $30.00 and gave the company a "market outperform" rating in a report on Friday, September 20th. Morgan Stanley increased their price target on American Healthcare REIT from $17.00 to $22.00 and gave the company an "overweight" rating in a report on Thursday, August 22nd. Finally, Bank of America boosted their target price on shares of American Healthcare REIT from $27.00 to $31.00 and gave the stock a "buy" rating in a research report on Tuesday, September 24th. One analyst has rated the stock with a hold rating and seven have given a buy rating to the company's stock. According to data from MarketBeat, American Healthcare REIT presently has an average rating of "Moderate Buy" and a consensus target price of $23.25.

View Our Latest Report on AHR

American Healthcare REIT Company Profile

(Free Report)

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.

Featured Stories

Institutional Ownership by Quarter for American Healthcare REIT (NYSE:AHR)

Should you invest $1,000 in American Healthcare REIT right now?

Before you consider American Healthcare REIT, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and American Healthcare REIT wasn't on the list.

While American Healthcare REIT currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

’Best Report in 2 Years’: NVIDIA Earnings Crushes Expectations Again
Palantir and the NASDAQ 100: What’s the Next Big Stock Swing for This AI Giant?
Rocket Lab Stock Explodes Higher—What’s Next for This Space Pioneer?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines